Jefferies Group LLC Rocket Pharmaceuticals, Inc. Call Options Transaction History

Jefferies Group LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Sep 21, 2023	BUY	$12.37 - $18.41 $1.12 Million - $1.67 Million	90,600 Added 963.83%	100,000 $1.6 Million
Q3 2022 Nov 14, 2022	BUY	$12.37 - $18.41 $1.24 Million - $1.84 Million	100,000 New	100,000 $1.6 Million
Q4 2021 Feb 14, 2022	SELL	$21.52 - $36.02 $202,288 - $338,588	-9,400 Closed	0 $0
Q2 2021 Sep 21, 2023	SELL	$39.41 - $47.25 $3.57 Million - $4.28 Million	-90,600 Reduced 90.6%	9,400 $416,000
Q2 2021 Aug 20, 2021	SELL	$39.41 - $47.25 $36.7 Million - $44 Million	-930,600 Reduced 99.0%	9,400 $416,000
Q2 2021 Aug 16, 2021	BUY	$39.41 - $47.25 $37 Million - $44.4 Million	940,000 New	940,000 $416,000

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $910M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.